Crossmark

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

Crossref DOI link: https://doi.org/10.1186/s12889-019-7983-7

Published Online: 2019-11-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burman, M. https://orcid.org/0000-0003-2873-5917
Copas, A.

Zenner, D.

Hickson, V.

Gosce, L.

Trathen, D.

Ashcroft, R.

Martineau, A. R.

Abubakar, I.

Griffiths, C.

Kunst, H.
Funding

Funding for this research was provided by:

Barts Charity (421/2301)
License Information

Text and Data Mining valid from 2019-11-29

Version of Record valid from 2019-11-29
More Information

Article History

Received: 1 October 2019

Accepted: 21 November 2019

First Online: 29 November 2019

Ethics approval and consent to participate

: Ethical approval for the trial was obtained from the Camden & Kings Cross Research Ethics Committee (16/LO/0328). Valid implied consent is assumed for participation in the trial. Eligible patients are asked for verbal consent to access their data which is in their electronic patient records.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below